Skip to content

Volitional Modification of Brain Activity in ASD

Volitional Modification of Brain Activity in ASD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012339
Enrollment
40
Registered
2017-04-20
Start date
2017-05-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F84.5 F84.1

Interventions

Group 1: Intervention1: 24 sessions Slow-Cortical-Potential Neurofeedback-Training during an app. 3-month intervention period (20 participants with ASD) Group 2: Intervention 2: Treatment as usual and

Sponsors

Medizinische Universität WienUniversitätsklinik für Kinder- & Jugendpsychiatrie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 17 Years

Inclusion criteria

Inclusion criteria: - Adolescents with autism spectrum disorder - Age from 12.00 to 17.11 years, male and female - IQ> 70, right-handed - Informed Consent, ability to understand study information and instructions (sufficient knowledge of German), signed declarations of consent/assent of study participant and of parent/legal guardian

Exclusion criteria

Exclusion criteria: - Severe neurological or medical diseases or severe head injuries - Axis I diagnosis: Psychotic Disorder, Tic-, Tourette- or OC- Disorder, severe depression with suicidality - Simultaneous participation in pharmacological study, former neurofeedback training - Any implant or stainless steel graft or any other contraindications for MRI - Failure to comply with the study protocol or to follow the instructions of the investigating team

Design outcomes

Primary

MeasureTime frame
The primary endpoint of this study is the SCP (Slow-Cortical-Potential)-activity (SCP-differentiation in feedback and transfer condition, e.g. average µV-amplitude difference between required positivity and negativity) in the beginning of the training compared to the SCP-activity in the end of the training.

Secondary

MeasureTime frame
Secondary endpoints are the raw values ??of the questionnaires as well as the reaction times from psychological, computerised test from t0 (before the interventions) compared to t1 (after the interventions). Here, the target variables are autistic symptoms, comorbid characteristics, emotional processes, cognitive abilities and behavioral responses.

Countries

Austria

Contacts

Public ContactLilian Konicar

Medizinische Universität WienUniversitätsklinik für Kinder- & Jugendpsychiatrie

lilian.konicar@meduniwien.ac.at0043 1 40 400 37460

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 12, 2026